Drug Search Results
More Filters [+]

Thiamphenicol

Alternative Names: thiamphenicol
Latest Update: 2024-04-25
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Protein Synthesis Inhibitor,Bacterial Growth Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Belgium | China | Colombia | Ecuador | Egypt | France | Hong Kong | Indonesia | Korea | Luxembourg | Malaysia | Morocco | Pakistan | Peru | Poland | Portugal | Russia | Saudi Arabia | South Africa | Taiwan | Tunisia | Turkey | Ukraine | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: Psyadon Pharma
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Thiamphenicol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Respiratory Tract Infections

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

EAAT2 Biomarker

P1

Completed

Healthy Volunteers

2007-09-01

2004-001901-81

P3

Terminated

Respiratory Tract Infections

None

Recent News Events